{"id":16474,"date":"2021-03-19T15:19:11","date_gmt":"2021-03-19T14:19:11","guid":{"rendered":"https:\/\/idibell.cat\/es\/?p=16474"},"modified":"2021-03-19T15:21:20","modified_gmt":"2021-03-19T14:21:20","slug":"el-dr-xavier-matias-guiu-nuevo-presidente-de-la-sociedad-internacional-de-patologos-ginecologicos","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2021\/03\/el-dr-xavier-matias-guiu-nuevo-presidente-de-la-sociedad-internacional-de-patologos-ginecologicos\/","title":{"rendered":"El Dr. Xavier Matias-Guiu, nuevo presidente de la Sociedad Internacional de Pat\u00f3logos Ginecol\u00f3gicos"},"content":{"rendered":"<p>La ISGYP (<a href=\"https:\/\/www.isgyp.org\/\">International Society of Gynecological Pathologists<\/a>) es una sociedad cient\u00edfica, de alcance mundial, de pat\u00f3logos con un inter\u00e9s com\u00fan por la patolog\u00eda del sistema reproductor femenino. La Sociedad se fund\u00f3 en 1976 para facilitar el intercambio de conocimientos sobre enfermedades ginecol\u00f3gicas y ser un foro de difusi\u00f3n de nueva informaci\u00f3n en esta \u00e1rea.<\/p>\n<p>La pertenencia est\u00e1 abierta a cualquier pat\u00f3logo de acuerdo con las normativas o costumbres de cada pa\u00eds para los especialistas y que haya contribuido al campo de la patolog\u00eda ginecol\u00f3gica.<\/p>\n<p>La ISGYP se encarga a nivel global de ser el interlocutor para cuestiones relativas a la patolog\u00eda de los c\u00e1nceres ginecol\u00f3gicos. Cuenta con un programa de formaci\u00f3n en patolog\u00eda ginecol\u00f3gica para pat\u00f3logos de todo el mundo, con la organizaci\u00f3n de reuniones conjuntamente con la divisi\u00f3n americano-canadiense de la Academia Internacional de Patolog\u00eda (USCAP), la Sociedad Americana de Patolog\u00eda Cl\u00ednica (ASCP), la Sociedad Internacional de C\u00e1ncer Ginecol\u00f3gico (IGCS) y la Sociedad Europea de Patolog\u00eda (ESP), entre otros.<\/p>\n<p>Desde hace un a\u00f1o, la ISGYP ha promovido la formaci\u00f3n virtual mediante el programa ISGYP-life, con cuatro sesiones mensuales, que ha tenido mucha aceptaci\u00f3n en todos los \u00e1mbitos geogr\u00e1ficos. La ISGYP tiene como publicaci\u00f3n propia el International Journal of Gynecological Pathology.<\/p>\n<p>Entre los objetivos que se plantea el Dr. Matias-Guiu, jefe de grupo en el <a href=\"https:\/\/idibell.cat\/es\/investigacion\/area-de-cancer\/programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell\/cancer-ginecologico\/\">IDIBELL<\/a> i jefe del Servicio de Anatom\u00eda Patol\u00f3gica del Hospital Universitario de Bellvitge, durante los dos a\u00f1os de presidencia est\u00e1n el mantenimiento del programa de formaci\u00f3n virtual m\u00e1s all\u00e1 de la situaci\u00f3n epidemiol\u00f3gica actual, incrementar la difusi\u00f3n de la ISGYP en todos los \u00e1mbitos geogr\u00e1ficos del mundo, especialmente en los pa\u00edses donde est\u00e1 menos implantada, incrementar la relaci\u00f3n con las asociaciones de enfermos con c\u00e1ncer ginecol\u00f3gico a nivel mundial, y promover un estudio multic\u00e9ntrico de alcance mundial para proporcionar evidencia cient\u00edfica para optimizar la estadificaci\u00f3n del c\u00e1ncer de endometrio.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>El Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) es un centro de investigaci\u00f3n en biomedicina creado en 2004. Est\u00e1 participado por el Hospital Universitario de Bellvitge y el Hospital de Viladecans del Instituto Catal\u00e1n de la Salud, el Instituto Catal\u00e1n de Oncolog\u00eda, la Universidad de Barcelona y el Ayuntamiento de L&#8217;Hospitalet de Llobregat.<\/em><\/p>\n<p><em>El IDIBELL es miembro del Campus de Excelencia Internacional de la Universidad de Barcelona HUBc y forma parte de la instituci\u00f3n CERCA de la Generalitat de Catalunya. En 2009 se convirti\u00f3 en uno de los cinco primeros centros de investigaci\u00f3n espa\u00f1oles acreditados como instituto de investigaci\u00f3n sanitaria por el Instituto de Salud Carlos III. Adem\u00e1s, forma parte del programa \u00abHR Excellence in Research\u00bb de la Uni\u00f3n Europea y es miembro de EATRIS y REGIC. Desde el a\u00f1o 2018, IDIBELL es un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Dr. Xavier Matias-Guiu, jefe del grupo de investigaci\u00f3n en c\u00e1ncer ginecol\u00f3gico del IDIBELL, es desde este fin de semana el nuevo presidente de la Sociedad Internacional de Pat\u00f3logos Ginecol\u00f3gicos (ISGYP).<\/p>\n","protected":false},"author":8,"featured_media":16475,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[184,253,281],"tags":[],"class_list":["post-16474","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-area-cancer","category-cancer-ginecologico","category-programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell"],"publishpress_future_action":{"enabled":false,"date":"2024-11-28 23:05:15","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/16474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=16474"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/16474\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/16475"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=16474"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=16474"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=16474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}